QuantRx Biomedical Corporation – OTC:QTXB

QuantRx Biomedical stock price today

$0.004
+0.00
+700%
Financial Health
0
1
2
3
4
5
6
7
8
9

QuantRx Biomedical stock price monthly change

-79.59%
month

QuantRx Biomedical stock price quarterly change

-79.59%
quarter

QuantRx Biomedical stock price yearly change

-87.34%
year

QuantRx Biomedical key metrics

Market Cap
 1.15M
Enterprise value
 3.21M
P/E
 -0.5
EV/Sales
 N/A
EV/EBITDA
 -72.63
Price/Sales
 N/A
Price/Book
 -0.13
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

QuantRx Biomedical stock price history

QuantRx Biomedical stock forecast

QuantRx Biomedical financial statements

Profit Margin

QuantRx Biomedical Corporation (OTC:QTXB): Profit margin
Dec 2022 0 0
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
QTXB income statement history

Debt to Assets

QuantRx Biomedical Corporation (OTC:QTXB): Debt to assets
Sep 2022 5383 2.84M 52869.18%
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
QTXB balance sheet history

Cash Flow

QuantRx Biomedical Corporation (OTC:QTXB): Cash Flow
Dec 2022 0 0 0
Mar 2023 0 0 0
Jun 2023 0 0 0
Sep 2023 0 0 0
QTXB cash flow history

QuantRx Biomedical other data

QuantRx Biomedical
Insider Trading

QuantRx Biomedical Corporation (OTC:QTXB): Insider trades (number of shares)
Period Buy Sel
Feb 2007 0 95000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
LEVINE EVAN director, 10 percent owner
 Common Stock 70,000 N/A N/A
Sale
LEVINE EVAN director, 10 percent owner
 Common Stock 25,000 N/A N/A
Option
HIRSCHMAN SHALOM director
 Common Stock 500,000 N/A N/A
QTXB insider trading transactions

QuantRx Biomedical
Executives

Insider Compensation
Dr. Shalom Z. Hirschman M.D. (1936) Chairman, Chief Executive Officer & Principal Accounting Officer
 $3,500

Frequently Asked Questions (FAQ)

  • What's the price of QuantRx Biomedical stock today?

    One share of QuantRx Biomedical stock can currently be purchased for approximately $0.

  • When is QuantRx Biomedical's next earnings date?

    Unfortunately, QuantRx Biomedical's (QTXB) next earnings date is currently unknown.

  • Does QuantRx Biomedical pay dividends?

    No, QuantRx Biomedical does not pay dividends.

  • How much money does QuantRx Biomedical make?

    QuantRx Biomedical has a market capitalization of 1.15M.

  • What is QuantRx Biomedical's stock symbol?

    QuantRx Biomedical Corporation is traded on the OTC under the ticker symbol "QTXB".

  • What is QuantRx Biomedical's primary industry?

    Company operates in the Healthcare sector and Medical Instruments & Supplies industry.

  • How do i buy shares of QuantRx Biomedical?

    Shares of QuantRx Biomedical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are QuantRx Biomedical's key executives?

    QuantRx Biomedical's management team includes the following people:

    • Dr. Shalom Z. Hirschman M.D. Chairman, Chief Executive Officer & Principal Accounting Officer(age: 89, pay: $3,500)

  • When QuantRx Biomedical went public?

    QuantRx Biomedical Corporation is publicly traded company for more then 21 years since IPO on 2 Jul 2004.

  • What is QuantRx Biomedical's official website?

    The official website for QuantRx Biomedical is quantrx.com.

  • Where are QuantRx Biomedical's headquarters?

    QuantRx Biomedical is headquartered at 10190 SW 90th Avenue, Tualatin, OR.

  • How can i contact QuantRx Biomedical?

    QuantRx Biomedical's mailing address is 10190 SW 90th Avenue, Tualatin, OR and company can be reached via phone at +212 9802235.

QuantRx Biomedical company profile:

QuantRx Biomedical Corporation

quantrx.com
Exchange:

OTC

Full time employees:

0

Industry:

Medical Instruments & Supplies

Sector:

Healthcare

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

+212 9802235
10190 SW 90th Avenue
Tualatin, OR 97062

CIK: 0000820608
ISIN: US74765N1090
CUSIP: 74765N109